UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025502
Receipt number R000029345
Scientific Title the effect of insulin glargine U300 on variability of glucose level before breakfast and change in HbA1c level -pre and post comparison test by switching from U100 to U300-
Date of disclosure of the study information 2017/02/01
Last modified on 2018/09/07 14:10:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

the effect of insulin glargine U300 on variability of glucose level before breakfast and change in HbA1c level
-pre and post comparison test by switching from U100 to U300-

Acronym

evaluation for Fasting PG stabilization by switching therapy from glargine to U300
(FASTAGLU300 Study)

Scientific Title

the effect of insulin glargine U300 on variability of glucose level before breakfast and change in HbA1c level
-pre and post comparison test by switching from U100 to U300-

Scientific Title:Acronym

evaluation for Fasting PG stabilization by switching therapy from glargine to U300
(FASTAGLU300 Study)

Region

Japan


Condition

Condition

diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of switching therapyfrom insulin glargine U100 to U300 in the
same unit on stability for glucose level before breakfast and change in HbA1c level after using self-titration algorithm (3-3-1 algorithm)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

1.Changes in mean value and standard deviation (SD)of fasting blood glucose in early morning
2.Changes in HbA1c and glycated albumin levels after self-titration algorithm (3-3-1 algorithm)

Key secondary outcomes

1.Contributing factors on SD of fasting blood glucose in early morning
2. Change in patient feeling of use
3. Change in body weight,blood pressure and lipid profile
4.symptomatic or severe hypoglycemia
5. another adverse events and side effects


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

switching from insulin glargine U100 to U300 in the same unit during 30 days

Interventions/Control_2

adjuasting insulin dose by using self-titration algorithm (3-3-1 algorithm) during 90
days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)patient with type 1 or 2 diabetes treated with once daily insulin glargin for moer than 12 weeks
(2) HbA1c(NGSP) 7.0 - 11.0%
(3) Patients who can continue self-monitoring of fasting blood glucose in early morning
(4) Age, 20 - 50 year old
(5) Patients who can agree to take part in this study

Key exclusion criteria

-Patients who do not consent to the study.
-Patients who have had severe ketosis or who have been in a diabetic coma or precoma within the past 6 months.
-Patients who have a severe infection, are in pre/post operation, or have a serious wound.
-Patients who are pregnant, lactating or may become pregnant.
-Patients judged by their primary physician that they are not appropriate to participate the study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukihiro Bando

Organization

Fukuiken Saisekai Hospital

Division name

Internal medicine

Zip code


Address

Funabashi Wadanaka 7-1,Fukui,Fukui.Japan

TEL

0776231111

Email

bando.yukihiro5002@fukui.saiseikai.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuo Notsumata

Organization

Fukuiken Saisekai Hospital

Division name

Internal medicine

Zip code


Address

Funabashi Wadanaka 7-1,Fukui,Fukui.Japan

TEL

0776231111

Homepage URL


Email

bando.yukihiro5002@fukui.saiseikai.or.jp


Sponsor or person

Institute

Fukuiken Saisekai Hospital

Institute

Department

Personal name



Funding Source

Organization

no source of funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 10 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 10 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry

2017 Year 10 Month 15 Day

Date trial data considered complete

2017 Year 10 Month 30 Day

Date analysis concluded

2017 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 03 Day

Last modified on

2018 Year 09 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029345


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name